3 Nisan 2019 Çarşamba

Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again


By DENISE GRADY from NYT Health Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules. https://ift.tt/2UfjXIc

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...